Montana Lures Bay Area Biotechs

After selling heart failure drug developer Corthera Inc. to Novartis AG, Stan Abel wanted to slow down. His father was sick. His wife was pregnant with twins.

So he went to Montana, and there he’s stayed even while leading his newest venture, SiteOne Therapeutics Inc. out of an incubator in San Francisco.

But Abel is far from the only life sciences entrepreneur or academic to land in Big Sky Country. Montana, the land of gold, silver and copper deposits, now is striking biotech veins.

MORE>>>San Francisco Business Times